{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:47:58Z","timestamp":1773960478823,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00296-019-04500-8","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T11:02:21Z","timestamp":1576926141000},"page":"777-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-8419","authenticated-orcid":false,"given":"Enrique","family":"Esteve-Valverde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Tapiz-Reula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-3619","authenticated-orcid":false,"given":"Jaume","family":"Alijotas-Reig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"key":"4500_CR1","first-page":"2521","volume-title":"Harrison\u2019s principles of internal medicine","author":"RJ Desnick","year":"2015","unstructured":"Desnick RJ, Balwani M (2015) The Porphyrias. In: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J (eds) Harrison\u2019s principles of internal medicine, 19th edn. McGraw Hill, New York, pp 2521\u20132533","edition":"19"},{"key":"4500_CR2","first-page":"298","volume":"3","author":"S Wolfram","year":"1952","unstructured":"Wolfram S (1952) Uber Porphyrinkolik, Ein Beitrag zur Symptomatologie des Erythematodes Acutus. Hautarzt 3:298\u2013300","journal-title":"Hautarzt"},{"key":"4500_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/ard.49.4.246","volume":"49","author":"SA Allard","year":"1990","unstructured":"Allard SA, Charles PJ, Herrick AL, McColl KEL, Scott TJ (1990) Antinuclear antibodies and the diagnosis of systemic lupus erythematosus in patients with acute intermitent porphyria. Ann Rheum Dis 49:246\u2013248","journal-title":"Ann Rheum Dis"},{"key":"4500_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1191\/0961203302lu159cr","volume":"11","author":"A Filiotou","year":"2002","unstructured":"Filiotou A, Vaiopoulos G, Capsimali V, Stavrianeas N, Kaloterakis A (2002) Acute intermittent porphyria and systemic lupus erythematosus: report of a case and review of the literature. Lupus 11:190\u2013192","journal-title":"Lupus"},{"key":"4500_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","volume":"16","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli C, Moroni G (2017) Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf 16:411\u2013419","journal-title":"Expert Opin Drug Saf"},{"key":"4500_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2019.06.014","volume":"67","author":"J Rigor","year":"2019","unstructured":"Rigor J, Pinto SA, Martins-Mendes D (2019) Porphyrias: a clinically based approach. Eur J Intern Med 67:24\u201329","journal-title":"Eur J Intern Med"},{"key":"4500_CR7","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110\u20132121","journal-title":"N Engl J Med"},{"key":"4500_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"4500_CR9","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686","journal-title":"Arthritis Rheum"},{"key":"4500_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hep4.1297","volume":"3","author":"B Wang","year":"2018","unstructured":"Wang B, Rudnick S, Cengia B, Bonkovsky HL (2018) Acute hepatic porphyrias: review and recent progress. Hepatol Commun 3:193\u2013206","journal-title":"Hepatol Commun"},{"key":"4500_CR11","unstructured":"European Prophyria Network (2019) https:\/\/porphyria.eu\/es\/content\/drugs-and-porphyria. Accessed 30 Apr 2019"},{"key":"4500_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/bjh.14459","volume":"176","author":"PE Stein","year":"2017","unstructured":"Stein PE, Badminton MN, Rees DC (2017) Update review of the acute porphyrias. Br J Haematol 176:527\u2013538","journal-title":"Br J Haematol"},{"key":"4500_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/0961203318768884","volume":"27","author":"B Sunkara","year":"2018","unstructured":"Sunkara B, Roofeh D, Silver S, LeBleu PT, Ettel M, McCune WJ (2018) The devil\u2019s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-na\u00efve patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Lupus 27:1383\u20131386","journal-title":"Lupus"},{"key":"4500_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3748\/wjg.v25.i7.880","volume":"25","author":"HM Liu","year":"2019","unstructured":"Liu HM, Deng GH, Mao Q, Wang XH (2019) Diagnosis of erythropoietic protoporphyria with severe liver injury: a case report. World J Gastroenterol 25:880\u2013887","journal-title":"World J Gastroenterol"},{"key":"4500_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12913-019-4285-9","volume":"19","author":"MH Hammersland","year":"2019","unstructured":"Hammersland MH, Aarsand AK, Sandberg S, Andersen J (2019) Self-efficacy and self-management strategies in acute intermittent porphyria. BMC Health Serv Res 19:444","journal-title":"BMC Health Serv Res"},{"key":"4500_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1258\/0004563011900344","volume":"38","author":"A De Siervi","year":"2001","unstructured":"De Siervi A, Varela LS, Parera VE, Batlle A, Rossetti MV (2001) Diagnosis of latent acute intermittent porphyria by genetic analysis. Ann Clin Biochem 38:149\u2013152","journal-title":"Ann Clin Biochem"},{"key":"4500_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1157\/13117900","volume":"31","author":"MY Raigal","year":"2008","unstructured":"Raigal MY, Navarro JL, Mart\u00edn JMR, Patino EM, P\u00e9rez EP, Prat MM (2008) Acute intermittent porphyria and chronic transaminases elevation. Gastroenterol y Hepatol 31:225\u2013228","journal-title":"Gastroenterol y Hepatol"},{"key":"4500_CR18","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/392049","author":"G-M Gonz\u00e1lez-EstradaA","year":"2011","unstructured":"EstradaA G-M, G\u00f3mez-Morales L, -Junco P (2011) Chronic elevation of liver enzymes in acute intermittent porphyria initially misdiagnosed as autoimmune hepatitis. Intern J Hepatol. https:\/\/doi.org\/10.4061\/2011\/392049","journal-title":"Intern J Hepatol"},{"key":"4500_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2133.1959.tb13411.x","volume":"71","author":"CW Marsden","year":"1959","unstructured":"Marsden CW (1959) Porphyria during chloroquine therapy. Br J Dermatol 71:219\u2013222","journal-title":"Br J Dermatol"},{"key":"4500_CR20","first-page":"299","volume":"12","author":"N Passaron","year":"1962","unstructured":"Passaron N, Loveras JH, Vasquez E (1962) Lupus erythematoso cr\u00f3nico exacerbado y porfiria aguda. Arch Argent Dermatol 12:299\u2013303","journal-title":"Arch Argent Dermatol"},{"key":"4500_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinte.1966.03870090109021","volume":"117","author":"MY Harris","year":"1966","unstructured":"Harris MY, Mills GL, Levin WC (1966) Coexistent systemic lupus erythematosus and porphyria. Arch Intern Med 117:425\u2013428","journal-title":"Arch Intern Med"},{"key":"4500_CR22","first-page":"1074","volume":"2","author":"R Quilichini","year":"1973","unstructured":"Quilichini R, Guerder A (1973) Systemic lupus erythematosus and acute intermittent porphyria. Nouv Press Med 2:1074","journal-title":"Nouv Press Med"},{"key":"4500_CR23","first-page":"1542","volume":"53","author":"F Vittori","year":"1977","unstructured":"Vittori F, Desaegher JL (1977) Lupus erythemateux disemine et porphyrie aigue intermittente. Association ou coincidence? Sem Hop Paris 53:1542\u20131548","journal-title":"Sem Hop Paris"},{"key":"4500_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.1780250917","volume":"25","author":"JI Rosemarin","year":"1982","unstructured":"Rosemarin JI, Nigro EJ, Levere NR, Mascarenhas BR (1982) Systemic lupus erythematosus and acute intermittent porphyria: coincidence or association? Arthritis Rheum 25:1134\u20131137","journal-title":"Arthritis Rheum"},{"key":"4500_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/rheumatology\/28.3.254","volume":"28","author":"SA Allard","year":"1989","unstructured":"Allard SA, Scott JT (1989) Systemic lupus erythematosus and acute intermittent porphyria. Br J Rheumatol 28:254\u2013256","journal-title":"Br J Rheumatol"},{"key":"4500_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2796.1994.tb01279.x","volume":"236","author":"C Andersson","year":"1994","unstructured":"Andersson C, Lithner F (1994) Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med 236:169\u2013175","journal-title":"J Intern Med"},{"key":"4500_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1468-3083.2006.02093.x","volume":"21","author":"A Bharati","year":"2007","unstructured":"Bharati A, Kleyn E, Wong GA, Leonard N, King CM (2007) A spectrum of lupus erythematosus from verrucous to systemic, coexisting with two types of porphyria. J Eur Acad Dermatol Venereol 21:1009\u20131010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4500_CR28","first-page":"60","volume":"63","author":"AD Patil","year":"2015","unstructured":"Patil AD, Karnik ND, Nadkar MY, Gupta VA, Muralidhara K, Passidhi S (2015) Guillain Barr\u00e9 syndrome, systemic lupus erythematosus and acute intermittent porphyria\u2014a deadly trio. J Assoc Physicians India 63:60\u201363","journal-title":"J Assoc Physicians India"},{"key":"4500_CR29","first-page":"535","volume":"19","author":"C Korkmaz","year":"2006","unstructured":"Korkmaz C (2006) Delayed diagnosis of porphyria based on manifestations of systemic lupus erythematosus and ankylosing spondylitis. J Nephrol 19:535\u2013539","journal-title":"J Nephrol"},{"key":"4500_CR30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","volume":"127","author":"HL Bonkovsky","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR et al (2014) Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med 127:1233\u20131241","journal-title":"Am J Med"},{"key":"4500_CR31","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384:1878\u20131888","journal-title":"Lancet"},{"key":"4500_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/TACG.S48605","volume":"8","author":"E Pischik","year":"2015","unstructured":"Pischik E, Kauppinen R (2015) An update of clinical management of acute intermittent porphyria. Appl Clin Genet 8:201\u2013214","journal-title":"Appl Clin Genet"},{"key":"4500_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3810\/pgm.2014.11.2839","volume":"126","author":"G Roveri","year":"2014","unstructured":"Roveri G, Nascimbeni F, Rocchi E, Ventura P (2014) Drugs and acute porphyrias: reasons for a hazardous relationship. Postgrad Med 126:108\u2013120","journal-title":"Postgrad Med"},{"key":"4500_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2165\/11588500-000000000-00000","volume":"34","author":"C Chang","year":"2011","unstructured":"Chang C, Gershwin ME (2011) Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf 34:357\u2013374","journal-title":"Drug Saf"},{"issue":"6 Pt 2","key":"4500_CR35","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/j.lpm.2014.03.007","volume":"43","author":"N Costedoat-Chalumeau","year":"2014","unstructured":"-Chalumeau N, Dunogu\u00e9 B, Morel N, Le Guern V, Guettrot-Imbert G (2014) Hydroxychloroquine: a multifaceted treatment in lupus. Presse Med 43(2):e167\u2013e180","journal-title":"Presse Med"},{"key":"4500_CR36","first-page":"442","volume-title":"Dubois\u2019 lupus erythematosus","author":"MJ Fritzler","year":"1994","unstructured":"Fritzler MJ, Rubin RL (1994) Drug-induced lupus. In: Wallace DJ, Hahn BH (eds) Dubois\u2019 lupus erythematosus, 4th edn. Lea & Febiger, Philadelphia, pp 442\u2013453","edition":"4"},{"key":"4500_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"I Ben-Zvi","year":"2012","unstructured":"Zvi I, Kivity S, Langevitz P, Shoenfeld Y (2012) Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 42:145\u2013153","journal-title":"Clin Rev Allergy Immunol"},{"key":"4500_CR38","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1177\/0961203318781008","volume":"27","author":"FR Spinelli","year":"2018","unstructured":"Spinelli FR, Moscarelli E, Ceccarelli F, Miranda F, Perricone C, Truglia S et al (2018) Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort. Lupus 27:1616\u20131623","journal-title":"Lupus"},{"key":"4500_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0961203312465782","volume":"22","author":"J Alijotas-Reig","year":"2013","unstructured":"Alijotas-Reig J (2013) Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management. Lupus 22:6\u201317","journal-title":"Lupus"},{"issue":"Suppl 1","key":"4500_CR40","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1177\/0961203396005001131","volume":"5","author":"DJ Wallace","year":"1996","unstructured":"Wallace DJ (1996) The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus 5(1):S59\u201364","journal-title":"Lupus"},{"key":"4500_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","volume":"20","author":"S Kalia","year":"2007","unstructured":"Kalia S, Dutz JP (2007) New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 20:160\u2013174","journal-title":"Dermatol Ther"},{"key":"4500_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12664-016-0698-0","volume":"35","author":"S Arora","year":"2016","unstructured":"Arora S, Young S, Kodali S, Singal AK (2016) Hepatic porphyria: a narrative review. Indian J Gastroenterol 35:405\u2013418","journal-title":"Indian J Gastroenterol"},{"key":"4500_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/0190-9622(92)70090-3","volume":"26","author":"CS Petersen","year":"1992","unstructured":"Petersen CS, Thomsen K (1992) High-dose hydroxychloroquine treatment of porphyria cutanea tarda. J Am Acad Dermatol 26:614\u2013619","journal-title":"J Am Acad Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04500-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04500-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04500-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T00:16:08Z","timestamp":1608423368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04500-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,21]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4500"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04500-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,21]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors state that they have no commercial or any other type of interest that may influence the drawing up of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent has been provided and added.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This work has not been published previously or is currently under consideration for publication elsewhere.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}